Lv1
90 积分 2024-01-18 加入
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer
2天前
已完结
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trial
3个月前
已完结
Triple-Negative Breast Cancer
3个月前
已完结
PARP Inhibitors for Breast Cancer Treatment
3个月前
已完结
The CDK4/6 inhibitor revolution — a game-changing era for breast cancer treatment
3个月前
已完结
Therapeutic resistance to anti-oestrogen therapy in breast cancer
3个月前
已完结
Optimal targeting of PI3K-AKT and mTOR in advanced oestrogen receptor-positive breast cancer
3个月前
已完结
Discovery, Characterization, and Structure-Based Optimization of Small-Molecule In Vitro and In Vivo Probes for Human DNA Polymerase Theta
4个月前
已完结
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
4个月前
已完结
Perioperative treatment strategies in EGFR-mutant early-stage NSCLC: current evidence and future challenges
10个月前
已完结
皖公网安备34019202002308
